Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-24 @ 5:58 PM
NCT ID:
NCT00053768
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed aggressive non-Hodgkin's lymphoma
* Previously untreated disease
* Favorable prognosis
* International Prognostic Index score of 0-1
* No more than 25% marrow involvement
PATIENT CHARACTERISTICS:
Age
* 18 to 60
Performance status
* ECOG 0-3 OR
* Karnofsky 40-100%
Life expectancy
* Not specified
Hematopoietic
* Platelet count at least 100,000/mm\^3
* WBC at least 2,500/mm\^3
Hepatic
* No active hepatitis infection
Renal
* Not specified
Other
* HIV negative
* Not pregnant or nursing
* No relevant accompanying disease
* No other concurrent malignancy
* No contraindications to any study medications
* No prior noncompliance by patient
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No prior chemotherapy
Endocrine therapy
* Not specified
Radiotherapy
* No prior radiotherapy
Surgery
* Not specified
Other
* No other concurrent participation in another treatment study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00053768
Study Brief:
Protocol Section:
NCT00053768